180 Life Sciences Corp.

Historical 13F Holders

Symbol
ETHZ
CUSIP
68236V302
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 68236V302 since 12/18/2024, largest first.

Filer % of Class Filed
Elray Resources, Inc. 13D/A
52.8% 4/11/2025
Event 3/27/2025
Steadfast Capital Management LP 13G
7.3% 8/12/2025
Event 8/4/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (8)
Electric Capital Partners Frontier Master Fund, LP 13G
Amended under CUSIP 68236V401 on 8/14/2026
8.6% 10/2/2025
Event 8/4/2025
FF Consumer Growth II, LP 13G
Amended under CUSIP 68236V401 on 2/17/2026
7.5% 8/11/2025
Event 8/4/2025
Citadel Securities GP LLC 13G
Amended under CUSIP 68236V401 on 2/17/2026
5.3% 9/25/2025
Event 9/18/2025
Intracoastal Capital LLC 13G
4.99% 1/3/2025
Event 12/27/2024
Ayrton Capital LLC 13G/A
4.6% 5/14/2025
Event 3/31/2025
Blair Jordan 13D/A 1.5% 8/6/2025
Event 7/24/2025
Anthony Brian Goodman 13D/A
0% 8/18/2025
Event 7/27/2025
Amtrust Financial Services, Inc. 13G/A
0% 7/22/2025
Event 7/17/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q3 60 38.8 M $93.5M
2025 Q2 12 35.0 k $32.9k
2025 Q1 11 28.1 k $27.6k
2024 Q4 13 460 k $837k
2024 Q3 7 23.8 k $40.3k
2024 Q2 8 7.07 k $11.6k
2024 Q1 8 22.6 k $52.6k